ClinicalTrials.gg
Drug

Exenatide clinical trials

Also written Byetta, Bydureon, AC2993 and Exendin-4.

studies test it
231
open now
1
in phase 3
70
first study started
2002

How each study uses Exenatide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Exenatide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Apr 2005 · BYETTA · NDA 021773 (FDA, Drugs@FDA)
European Union
20 Nov 2006 · Byetta · EMEA/H/C/000698 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Exenatide
147
exenatide once weekly
12
synthetic exendin-4
8
Exenatide Injection
4
Byetta (exenatide)
3

Brand

Byetta
91
Bydureon
33
Bydureon BCise
1

Development codes

AC2993
12
Exendin-4
4
ITCA 650
3
LY2148568
3

Studies by the year they started

231 studies that test it; most in 2008 (24)

Studies that test Exenatide, by start year
YearStudies
20027
20035
20044
20055
200612
200715
200824
200921
201019
20119
20128
201318
201417
201516
201617
201713
20184
20195
20203
20214
20221
20231
20243

By phase

A phase 1/2 study counts in both.

Phase 1
31
Phase 2
49
Phase 3
70
Phase 4
74
No phase
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 83 · Other 148

AstraZeneca (60) · Intarcia Therapeutics (10) · Amsterdam UMC, location VUmc (6) · University College, London (4) · The University of Texas Health Science Center, Houston (4) · The University of Texas Health Science Center at San Antonio (4) · Baylor College of Medicine (4) · Seattle Children's Hospital (3)

Often tested with

Tested in the same studies.

Dapagliflozin (6) · Sitagliptin (6) · Insulin Glargine (4) · Liraglutide (4) · Pioglitazone (3) · Pramlintide (2) · Oxygen (1) · Glucagon (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Exenatide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 231

See all 231 studies that test Exenatide →

Given beside what is tested · 5 — Exenatide is usual care or a partner of the new treatment
As the comparator · 13 — what is tested is compared with Exenatide

Codes

What other systems call Exenatide · ClinicalTrials.gg INT006683

  • MeSH (NLM) D000077270ExenatideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9P1872D4OLEXENATIDEConfirmed FDA, NLM
  • RxNorm 60548One source FDA
  • NCI Thesaurus C65611ExenatideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.